Trial intelligence / Profile preview

AGE-Benfo: Benfotiamine and AGE Meals in Type 2 Diabetes

NCT00437008Phase 4Completed

Sponsor
Ruhr University Bochum
Start
Nov 2004
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of benfotiamine in type 2 diabetes mellitus (T2DM), sponsored by Ruhr University Bochum. Started Nov 2004; status: completed.

02

Drugs

benfotiamine
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on NCT00437008.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00437008.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call